Wiley Clinical Health,
Check out this multicenter, double‐blind, randomized trial of #emricasan in hepatitis C-treated liver transplant recipients…
Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis
Overview of attention for article published in Liver Transplantation, April 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (74th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (56th percentile)
Readers on
- mendeley
- 23 Mendeley